Apogenix Gmbh
Apogenix develops innovative immunotherapeutics for the treatment of cancer and viral infections, such as COVID-19. The company has built a promising pipeline of drug candidates that target different TNFSF-dependent signaling pathways, thereby reducing lymphopenia and inflammatory cell death in patients with viral infections and restoring the anti-tumor immune response in cancer patients.
7-day free trial · no credit card
Verified contacts
7
available on Kipplo
LinkedIn employees
18
51 to 200 range
Open roles
—
no listings
Distinct roles
6
indexed titles
Tech stack
1
tools in use
Monthly traffic
45
organic / mo
Sign up free to see all 7 verified contacts at Apogenix Gmbh
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
7 contacts with verified email or phone · masked until revealed.
No verified contacts on record for this company yet.
Top roles at Apogenix Gmbh
6 distinct titles indexed · top 6 shown.
- 2research associate
- 1bürokauffrau
- 1clinical project manager
- 1clinical trial assistant
- 1director
- 1vp cmc project management
Sign up to unlock all 7 contacts at Apogenix Gmbh
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 7 verified contacts at Apogenix Gmbh
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.